Despite the Trump administration's tariff threats and pressure to move more manufacturing to the U.S., the push to raise ...

With AI expected to play a significant role in drug approvals, how can companies build data sets that are ready for AI?

Merck has announced the acquisition of SpringWorks, which is expected to close this year, for an enterprise value of EUR 3 billion. While the deal appears expensive at an 18 times price/sales multiple ...

Shares of Hikal hit a 52-week low of ₹281.90, falling 8 per cent on the BSE in Thursday's intra-day trade after the pharma company posted a net loss of ₹22.4 crore in Q1FY26.

The global trading system is adjusting to the tariffs levied by the United States: for most goods they look likely to settle ...

Pfizer is the closest company to producing a Lyme disease vaccine. Experts are concerned that vaccine skepticism could stand in its way.

The 2025 Clinical Trial Supply West Coast conference will gather experts to discuss US trial operations in a shifting tariff ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere in ...

CTI Chairman Brijesh Goyal has written to Prime Minister Narendra Modi, urging swift and strategic action, including imposing ...

The Indian pharmaceutical industry has been excluded from the United States' latest round of tariff hikes, with Washington ...

Primary packaging is never an afterthought in the world of injectable drugs, where systems such as vials, syringes, and ...

Emma Charles shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and ...